GRI Bio, Inc.
GRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $23 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $12 | $0 | $0 | $0 |
| Gross Profit | $11 | $0 | $0 | $0 |
| % Margin | 48.4% | – | – | – |
| R&D Expenses | $4 | $3 | $0 | $0 |
| G&A Expenses | $4 | $8 | $2 | $1 |
| SG&A Expenses | $4 | $8 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $11 | $2 | $1 |
| Operating Income | -$8 | -$11 | -$2 | -$1 |
| % Margin | -36.5% | – | – | – |
| Other Income/Exp. Net | $0 | -$2 | -$1 | -$0 |
| Pre-Tax Income | -$8 | -$13 | -$3 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8 | -$13 | -$3 | -$2 |
| % Margin | -36.4% | – | – | – |
| EPS | -55.21 | -6,242.18 | -165,346 | -815.8 |
| % Growth | 99.1% | 96.2% | -20,168% | – |
| EPS Diluted | -55.21 | -6,242.18 | -165,346 | -815.8 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $2 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | -$11 | -$3 | -$1 |
| % Margin | -36.5% | – | – | – |